Abstract
Objectives: Women with BRCA mutations have an elevated risk of developing breast cancer and epithelial ovarian cancer (EOC) (ovary, fallopian tube, and peritoneal carcinomas). We compared the costs of breast cancer surveillance between BRCA mutation carriers and women without mutations (WT) following a diagnosis of EOC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have